Edward George Neilan, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cockayne Syndrome | 4 | 2018 | 20 | 0.700 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2017 | 23 | 0.590 |
Why?
|
Hyperammonemia | 1 | 2017 | 77 | 0.540 |
Why?
|
Werner Syndrome | 1 | 2009 | 12 | 0.330 |
Why?
|
DNA Repair Enzymes | 3 | 2018 | 345 | 0.330 |
Why?
|
Carbidopa | 1 | 2008 | 30 | 0.320 |
Why?
|
Lamin Type A | 1 | 2009 | 187 | 0.300 |
Why?
|
Lipodystrophy | 1 | 2009 | 148 | 0.300 |
Why?
|
Levodopa | 1 | 2008 | 217 | 0.290 |
Why?
|
Meningocele | 1 | 2006 | 46 | 0.270 |
Why?
|
Chromosome Inversion | 1 | 2006 | 120 | 0.260 |
Why?
|
Anterior Chamber | 1 | 2006 | 194 | 0.260 |
Why?
|
DNA Helicases | 3 | 2018 | 854 | 0.250 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2006 | 377 | 0.250 |
Why?
|
Movement Disorders | 1 | 2008 | 459 | 0.240 |
Why?
|
alpha-Glucosidases | 1 | 2024 | 45 | 0.230 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2024 | 43 | 0.230 |
Why?
|
Eye Abnormalities | 1 | 2006 | 241 | 0.230 |
Why?
|
Abnormalities, Multiple | 1 | 2006 | 1415 | 0.160 |
Why?
|
Rare Diseases | 1 | 2024 | 619 | 0.160 |
Why?
|
RNA Splice Sites | 1 | 2018 | 211 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 1999 | 652 | 0.130 |
Why?
|
Wolman Disease | 1 | 2015 | 3 | 0.130 |
Why?
|
Sterol Esterase | 1 | 2015 | 40 | 0.130 |
Why?
|
Maple Syrup Urine Disease | 1 | 2014 | 40 | 0.120 |
Why?
|
Genetic Vectors | 2 | 2024 | 3380 | 0.110 |
Why?
|
Phospholipase C beta | 1 | 2012 | 49 | 0.100 |
Why?
|
Lactation | 1 | 2014 | 397 | 0.100 |
Why?
|
Chromosome Disorders | 1 | 2014 | 499 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 1999 | 1842 | 0.090 |
Why?
|
Protein Stability | 1 | 2012 | 566 | 0.090 |
Why?
|
Aging | 1 | 2009 | 8652 | 0.090 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2009 | 105 | 0.080 |
Why?
|
Epilepsies, Partial | 1 | 2012 | 430 | 0.080 |
Why?
|
Osteitis Deformans | 1 | 2008 | 54 | 0.080 |
Why?
|
Registries | 1 | 2024 | 8458 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2869 | 0.070 |
Why?
|
Ultraviolet Rays | 1 | 2012 | 1078 | 0.070 |
Why?
|
Ear | 1 | 2006 | 172 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2013 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2668 | 0.060 |
Why?
|
Infant | 4 | 2018 | 36053 | 0.060 |
Why?
|
Enzyme Replacement Therapy | 1 | 2024 | 79 | 0.060 |
Why?
|
Otitis Media | 1 | 2006 | 285 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 833 | 0.060 |
Why?
|
Muscular Diseases | 1 | 2008 | 551 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2009 | 819 | 0.050 |
Why?
|
DNA Damage | 2 | 2012 | 2442 | 0.050 |
Why?
|
DNA Repair | 1 | 2012 | 2038 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3280 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9406 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 965 | 0.050 |
Why?
|
Mutation | 2 | 2018 | 29957 | 0.050 |
Why?
|
Cleft Lip | 1 | 2006 | 504 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11902 | 0.040 |
Why?
|
Cleft Palate | 1 | 2006 | 587 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2014 | 2942 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2009 | 2567 | 0.040 |
Why?
|
Moloney murine leukemia virus | 1 | 1999 | 109 | 0.040 |
Why?
|
Dependovirus | 1 | 2024 | 709 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4938 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2024 | 1204 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3267 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7593 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6498 | 0.040 |
Why?
|
Male | 10 | 2024 | 359718 | 0.040 |
Why?
|
Gene Products, env | 1 | 1999 | 250 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 1999 | 575 | 0.040 |
Why?
|
Family | 1 | 2008 | 3189 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3448 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1999 | 1763 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3774 | 0.030 |
Why?
|
Humans | 14 | 2024 | 760613 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1999 | 1754 | 0.030 |
Why?
|
RNA Splicing | 1 | 1999 | 915 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2014 | 185 | 0.030 |
Why?
|
Dementia | 1 | 2008 | 2650 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1999 | 4169 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 607 | 0.030 |
Why?
|
Child, Preschool | 3 | 2024 | 42056 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9468 | 0.030 |
Why?
|
Nutritional Requirements | 1 | 2014 | 275 | 0.030 |
Why?
|
Pedigree | 2 | 2012 | 4578 | 0.030 |
Why?
|
Female | 8 | 2024 | 391246 | 0.020 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 263 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 87809 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16548 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4108 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2006 | 4673 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2014 | 656 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1628 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1817 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 894 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2012 | 537 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2015 | 895 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 18955 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1788 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4571 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2651 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5039 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2008 | 281 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2129 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 1999 | 9530 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17624 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2420 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2846 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1741 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36286 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4263 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 4089 | 0.010 |
Why?
|
Young Adult | 2 | 2024 | 58748 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6771 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39262 | 0.010 |
Why?
|
Child | 2 | 2024 | 79799 | 0.010 |
Why?
|
Adult | 4 | 2024 | 220007 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12427 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15620 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7510 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81209 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 220359 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6189 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16932 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7064 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17790 | 0.010 |
Why?
|
Neurons | 1 | 2014 | 9424 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.010 |
Why?
|
Animals | 2 | 2014 | 167960 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 4924 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 80345 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12102 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 29746 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 64981 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 25941 | 0.000 |
Why?
|
Aged | 1 | 2015 | 169143 | 0.000 |
Why?
|